Ranbaxy and Sun Pharma merger approved
December 9, 2014Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, cci, tamsulosin, tolterodine
The Competition Commission of India (CCI) has approved Sun Pharma’s acquisition of struggling drugmaker Ranbaxy, subject to conditions designed to …
Pfizer buys into gene therapy
December 9, 2014Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics
Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …
Celgene appoints new UK general manager
December 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Wim Souverijns
Celgene has appointed Wim Souverijns as its new vice president and general manager for UK and Ireland. Souverijns (pictured) takes …
AZ triumphs in Nexium pay-for-delay trial
December 8, 2014Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole
AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …
Updated: Merck buys antibiotics specialist Cubist
December 8, 2014Sales and Marketing Antibiotics, Merck, Novartis, cubicin, cubist, eumer
Merck has purchased US antibiotics maker Cubist in a deal valued at $9.5 billion. The acquisition values Cubist at around …
Blackberry creates cancer diagnostic tool
December 8, 2014Medical Communications, Sales and Marketing Blackberry, chen, diagnostic, nanthealth, passport, soon-shiong
Canadian smartphone maker Blackberry is entering the healthcare arena with a cancer diagnostic tool aimed at doctors and nurses. Via …
Merck and Galderma breach ABPI code
December 8, 2014Medical Communications, Sales and Marketing ABPI, Erbitux, Galderma, PMCPA, merch
Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code …
Analysis finds no Actos bladder cancer link
December 8, 2014Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2
A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …
The valuable world of Real World Evidence
December 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency
What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …
ABPI appoints first manufacturing director
December 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie
The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …
Bayer files haemophilia drug in EU
December 5, 2014Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate
Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …
GSK cancels sale of established products
December 5, 2014Medical Communications, Sales and Marketing FDA, GSK, Paxil, Seroxat, Zantac, bribery, cuts, imitrex
GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …
Merck sells manufacturing facility to Sanofi
December 5, 2014Manufacturing and Production, Sales and Marketing Merck, Merial, Puerto Rico, Sanofi, manufacturing
Sanofi’s animal health unit Merial is acquiring Merck’s manufacturing facility in Barceloneta, Puerto Rico. The proposed transaction requires the nod …
Ranbaxy launches J&J biosimilar in India
December 5, 2014Manufacturing and Production, Sales and Marketing CHMP, FDA, India, J&J, JJ, Ranbaxy, Remicade, nlem, nppa
Ranbaxy has launched the first biosimilar of Johnson & Johnson’s Remicade (infliximab) in India, marking the firm’s entry into monoclonal …
Speedy FDA nod for Amgen leukaemia drug
December 5, 2014Research and Development, Sales and Marketing B-cell lymphoblasts, FDA, Kyprolis, blinatumomab, blincyto, leukaemia
The FDA has approved Amgen’s Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukaemia (B-cell ALL). …
IDEA Pharma appoints two vice presidents
December 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90px, IDEA Pharma, kelly, weston
IDEA Pharma has hired both Samantha Weston and Paul Kelly as vice presidents in business development to boost the company’s …
Actavis to axe 200 jobs
December 4, 2014Medical Communications, Sales and Marketing Actavis, Allergan, Forest, GSK, Warner Chilcott, corona, stevenage
Actavis is set to cut 200 jobs in the US just weeks after buying Allergan for $66 billion. The lay-offs …
Government seeks stakeholder consultation over NICE
December 4, 2014Sales and Marketing ABPI, NHS, NICE, UK, emms, freeman, government, ndpb
NICE stakeholders are being asked for their views on its future as part of the government’s ongoing review into the …
Astellas ‘app challenge’ aims to inspire future talent
December 4, 2014Medical Communications, Sales and Marketing Astellas, CDF, CRUK, Ken Jones, app, my jar, stem
Last week Astellas announced the winner of its Science, Technology, Engineering, and Mathematics (STEM) skills Innovation Challenge competition at an …
Merck Ebola vaccine shows promise
December 4, 2014Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics
Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
